AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-91
Results: 1-25/91
PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T)
Authors: WALKER RE CARTER CS MUUL L NATARAJAN V HERPIN BR LEITMAN SF KLEIN HG MULLEN CA METCALF JA BASELER M FALLOON J DAVEY RT KOVACS JA POLIS MA MASUR H BLAESE RM LANE HC
Citation: Re. Walker et al., PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T), Nature medicine, 4(7), 1998, pp. 852-856
PRACTICE GUIDELINES FOR EVALUATING NEW FEVER IN CRITICALLY ILL ADULT PATIENTS
Authors: OGRADY NP BARIE PS BARTLETT JG BLECK T GARVEY G JACOBI J LINDEN P MAKI DG NAM M PASCULLE W PASQUALE MD TRIBETT DL MASUR H
Citation: Np. Ogrady et al., PRACTICE GUIDELINES FOR EVALUATING NEW FEVER IN CRITICALLY ILL ADULT PATIENTS, Clinical infectious diseases, 26(5), 1998, pp. 1042-1059
PNEUMONIA IN AIDS PATIENTS IN THE CRITICAL CARE UNIT
Authors: DECKER CF MASUR H
Citation: Cf. Decker et H. Masur, PNEUMONIA IN AIDS PATIENTS IN THE CRITICAL CARE UNIT, Critical care clinics, 14(1), 1998, pp. 135
POSTEXCITATORY INHIBITION AFTER TRANSCRANIAL MAGNETIC STIMULATION OF THE MOTOR CORTEX IN PATIENTS WITH DRUG-INDUCED PARKINSONISM AND IN HEALTHY-INDIVIDUALS
Authors: MASUR H ALTHOFF S ERIM Y OBERWITTLER C HORNUNG WP
Citation: H. Masur et al., POSTEXCITATORY INHIBITION AFTER TRANSCRANIAL MAGNETIC STIMULATION OF THE MOTOR CORTEX IN PATIENTS WITH DRUG-INDUCED PARKINSONISM AND IN HEALTHY-INDIVIDUALS, International clinical psychopharmacology, 13(2), 1998, pp. 79-82
FAILURE OF COTRIMOXAZOLE IN PNEUMOCYSTIS-CARINII INFECTION AND MUTATIONS IN DIHYDROPTEROATE SYNTHASE GENE
Authors: MEI Q GURUNATHAN S MASUR H KOVACS JA
Citation: Q. Mei et al., FAILURE OF COTRIMOXAZOLE IN PNEUMOCYSTIS-CARINII INFECTION AND MUTATIONS IN DIHYDROPTEROATE SYNTHASE GENE, Lancet, 351(9116), 1998, pp. 1631-1632
PRACTICE PARAMETERS FOR EVALUATING NEW FEVER IN CRITICALLY-ILL ADULT PATIENTS
Authors: OGRADY NP BARIE PS BARTLETT J BLECK T GARVEY G JACOBI J LINDEN P MAKI DG NAM M PASCULLE W PASQUALE MD TRIBETT DL MASUR H
Citation: Np. Ogrady et al., PRACTICE PARAMETERS FOR EVALUATING NEW FEVER IN CRITICALLY-ILL ADULT PATIENTS, Critical care medicine, 26(2), 1998, pp. 392-408
SUPERRIGIDITY AND MAPPING CLASS-GROUPS
Authors: FARB B MASUR H
Citation: B. Farb et H. Masur, SUPERRIGIDITY AND MAPPING CLASS-GROUPS, Topology (Oxford), 37(6), 1998, pp. 1169-1176
3-DIMENSIONAL MR-IMAGING OF NEUROVASCULAR COMPRESSION IN TRIGEMINAL NEURALGIA
Authors: PAPKE K BONGARTZ G MASUR H SCHUIERER G
Citation: K. Papke et al., 3-DIMENSIONAL MR-IMAGING OF NEUROVASCULAR COMPRESSION IN TRIGEMINAL NEURALGIA, Radiology, 208(2), 1998, pp. 550-551
REPORT OF THE NIH PANEL TO DEFINE PRINCIPLES OF THERAPY OF HIV-INFECTION
Authors: CARPENTER C FEINBERG M AUBRY W AVERITT D COFFIN J COOPER D FOLLANSBEE S HAMBURG P HARRINGTON M HIDALGO J JAFFE H LANDERS D MASUR H PIZZO P RICHMAN D SAAG M SCHOOLEY R STONE V THOMPSON M TRONO D VELLA S WALKER B YENI P
Citation: C. Carpenter et al., REPORT OF THE NIH PANEL TO DEFINE PRINCIPLES OF THERAPY OF HIV-INFECTION, Annals of internal medicine, 128(12), 1998, pp. 1057-1078
GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS
Authors: ANDERSON J ARMSTEAD R BAKER AC BARR D BOZZETTE S COX S DELANEY M GORDIN F GREAVES W HARRINGTON M HENNING JJ HIRSCH MS JACOBS J MARLINK R MAXWELL C MELLORS JW NASH DB PERRYMAN S SCHOOLEY RT SHERER R SPECTOR SA TORRES G VOLBERDING P BRADY BA COHEN O DANIELS EM FEIGAL D FEINBERG M GAYLE HD GRAYDON TR KAPLAN J MACHER A MARTIN RF MASUR H MOFENSON L MURRAY J ONEILL J PEREZ LC RISEBERG R SHEKAR S STANLEY SK WHITESCARVER J CARPENTER C BALLY G RACHLIS A STANLEY SK BRADY BA DANIELS EM
Citation: J. Anderson et al., GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS, Annals of internal medicine, 128(12), 1998, pp. 1079-1100
HIV-INFECTION INDUCES CHANGES IN CD4(-CELL PHENOTYPE AND DEPLETIONS WITHIN THE CD4(+) T-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES() T)
Authors: CONNORS M KOVACS JA KREVAT S GEABANACLOCHE JC SNELLER MC FLANIGAN M METCALF JA WALKER RE FALLOON J BASELER M STEVENS R FEUERSTEIN I MASUR H LANE HC
Citation: M. Connors et al., HIV-INFECTION INDUCES CHANGES IN CD4(-CELL PHENOTYPE AND DEPLETIONS WITHIN THE CD4(+) T-CELL REPERTOIRE THAT ARE NOT IMMEDIATELY RESTORED BY ANTIVIRAL OR IMMUNE-BASED THERAPIES() T), Nature medicine, 3(5), 1997, pp. 533-540
LACK OF CLINICAL UTILITY OF BRONCHOALVEOLAR LAVAGE CULTURES FOR CYTOMEGALOVIRUS IN HIV-INFECTION
Authors: MANN M SHELHAMER JH MASUR H GILL VJ TRAVIS W SOLOMON D MANISCHEWITZ J STOCK F LANE HC OGNIBENE FP
Citation: M. Mann et al., LACK OF CLINICAL UTILITY OF BRONCHOALVEOLAR LAVAGE CULTURES FOR CYTOMEGALOVIRUS IN HIV-INFECTION, American journal of respiratory and critical care medicine, 155(5), 1997, pp. 1723-1728
PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: MASUR H KAPLAN JE HOLMES KK BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Clinical infectious diseases, 25, 1997, pp. 299
1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/
Authors: MASUR H KAPLAN JE HOLMES KK ARMSTRONG D BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 25, 1997, pp. 313-335
EDITORIAL RESPONSE - LABORATORY MONITORING OF CYTOMEGALOVIRUS DISEASE- IS POLYMERASE CHAIN-REACTION THE ANSWER
Authors: FISCHER SH MASUR H
Citation: Sh. Fischer et H. Masur, EDITORIAL RESPONSE - LABORATORY MONITORING OF CYTOMEGALOVIRUS DISEASE- IS POLYMERASE CHAIN-REACTION THE ANSWER, Clinical infectious diseases, 24(5), 1997, pp. 841-842
BILATERAL PERIVENTRICULAR NODULAR HETEROTOPIA PET AND MRI OF A PATIENT WITH FOCAL SEIZURES
Authors: HAASE CG MASUR H MATHEJA P KUWERT T SCHOBER O
Citation: Cg. Haase et al., BILATERAL PERIVENTRICULAR NODULAR HETEROTOPIA PET AND MRI OF A PATIENT WITH FOCAL SEIZURES, Clinical nuclear medicine, 22(2), 1997, pp. 119-120
PREVENTING OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HIV - 1997 GUIDELINES
Authors: KAPLAN JE MASUR H JAFFE HW HOLMES KK
Citation: Je. Kaplan et al., PREVENTING OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HIV - 1997 GUIDELINES, JAMA, the journal of the American Medical Association, 278(4), 1997, pp. 337-338
PREVENTING OPPORTUNISTIC INFECTIONS IN HIV-INFECTED INJECTION-DRUG USERS - REPLY
Authors: KAPLAN JE JAFFE HW MASUR H HOLMES KK
Citation: Je. Kaplan et al., PREVENTING OPPORTUNISTIC INFECTIONS IN HIV-INFECTED INJECTION-DRUG USERS - REPLY, JAMA, the journal of the American Medical Association, 278(21), 1997, pp. 1743-1744
CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: POLIS MA PISCITELLI SC VOGEL S WITEBSKY FG CONVILLE PS PETTY B KOVACS JA DAVEY RT WALKER RE FALLOON J METCALF JA CRAFT C LANE HC MASUR H
Citation: Ma. Polis et al., CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1709-1714
SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS
Authors: DAVEY RT CHAITT DG PISCITELLI SC WELLS M KOVACS JA WALKER RE FALLOON J POLIS MA METCALF JA MASUR H FYFE G LANE HC
Citation: Rt. Davey et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS, The Journal of infectious diseases, 175(4), 1997, pp. 781-789
DRUG-INTERACTIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: PISCITELLI SC FLEXNER C MINOR JR POLIS MA MASUR H
Citation: Sc. Piscitelli et al., DRUG-INTERACTIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(4), 1996, pp. 685-693
GUIDE TO MAJOR CLINICAL-TRIALS OF ANTIRETROVIRAL THERAPY ADMINISTEREDTO PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SPOONER KM LANE HC MASUR H
Citation: Km. Spooner et al., GUIDE TO MAJOR CLINICAL-TRIALS OF ANTIRETROVIRAL THERAPY ADMINISTEREDTO PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(1), 1996, pp. 15-27
SECONDARY PROPHYLAXIS FOR TUBERCULOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - REPLY
Authors: CASTRO KG BLINKHORN RJ ELLNER JJ CHAISSON RE HORSBURGH CR MASUR H HOLMES KK KAPLAN JE
Citation: Kg. Castro et al., SECONDARY PROPHYLAXIS FOR TUBERCULOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - REPLY, Clinical infectious diseases, 22(2), 1996, pp. 399-400
PHYSICIAN STAFFING IN INTENSIVE-CARE UNITS
Authors: CUNNION RE MASUR H
Citation: Re. Cunnion et H. Masur, PHYSICIAN STAFFING IN INTENSIVE-CARE UNITS, Lancet, 348(9040), 1996, pp. 1464-1465
RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/
Authors: DAVEY RT CHAITT DG REED GF FREIMUTH WW HERPIN BR METCALF JA EASTMAN PS FALLOON J KOVACS JA POLIS MA WALKER RE MASUR H BOYLE J COLEMAN S COX SR WATHEN L DAENZER CL LANE HC
Citation: Rt. Davey et al., RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1657-1664
Risultati: 1-25 | 26-50 | 51-75 | 76-91